Skip to content
10-Q

Quarterly Report

Connect Biopharma Holdings Ltd CNTB

0001835268-25-000058

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 55.9M sh
Shares Diluted Q3 2025 · Sep 30, 2025 55.72M sh
Shares Diluted Q3 2025 · Sep 30, 2025 55.52M sh
Shares Diluted Q3 2025 · Sep 30, 2024 55.25M sh
Shares Diluted Q3 2025 · Sep 30, 2024 55.18M sh
Capex Q3 2025 · Sep 30, 2025 $418K
Capex Q3 2025 · Sep 30, 2024 $437K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$39.96M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$21.29M
Short Term Investments Q3 2025 · Sep 30, 2025 $16.94M
Short Term Investments Q3 2025 · Dec 31, 2024 $15.48M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $37.85M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $78.23M
Stockholders Equity Q3 2025 · Sep 30, 2025 $55.37M
Stockholders Equity Q3 2025 · Jun 30, 2025 $71.34M
Stockholders Equity Q3 2025 · Mar 31, 2025 $82.9M
Stockholders Equity Q3 2025 · Dec 31, 2024 $92.17M
Stockholders Equity Q3 2025 · Sep 30, 2024 $100.65M
Stockholders Equity Q3 2025 · Jun 30, 2024 $110.93M
Stockholders Equity Q3 2025 · Mar 31, 2024 $93.9M
Stockholders Equity Q3 2025 · Dec 31, 2023 $101.5M
Current Liabilities Q3 2025 · Sep 30, 2025 $11.43M
Current Liabilities Q3 2025 · Dec 31, 2024 $8.46M
Total Liabilities Q3 2025 · Sep 30, 2025 $11.99M
Total Liabilities Q3 2025 · Dec 31, 2024 $9.12M
Current Assets Q3 2025 · Sep 30, 2025 $62.6M
Current Assets Q3 2025 · Dec 31, 2024 $96.96M
Total Assets Q3 2025 · Sep 30, 2025 $67.36M
Total Assets Q3 2025 · Dec 31, 2024 $101.28M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.31
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.73
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.23
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.12
Eps Basic Q3 2025 · Sep 30, 2025 −$0.31
Eps Basic Q3 2025 · Sep 30, 2025 −$0.73
Eps Basic Q3 2025 · Sep 30, 2024 −$0.23
Eps Basic Q3 2025 · Sep 30, 2024 −$0.12
Sga Expense Q3 2025 · Sep 30, 2025 $6.58M
Sga Expense Q3 2025 · Sep 30, 2025 $16.1M
Sga Expense Q3 2025 · Sep 30, 2024 $6.06M
Sga Expense Q3 2025 · Sep 30, 2024 $15.15M
Rd Expense Q3 2025 · Sep 30, 2025 $11.11M
Rd Expense Q3 2025 · Sep 30, 2025 $26.52M
Rd Expense Q3 2025 · Sep 30, 2024 $9.01M
Rd Expense Q3 2025 · Sep 30, 2024 $23.02M
Net Income Q3 2025 · Sep 30, 2025 −$17.2M
Net Income Q3 2025 · Sep 30, 2025 −$40.37M
Net Income Q3 2025 · Jun 30, 2025 −$12.9M
Net Income Q3 2025 · Mar 31, 2025 −$10.27M
Net Income Q3 2025 · Sep 30, 2024 −$12.88M
Net Income Q3 2025 · Sep 30, 2024 −$6.72M
Net Income Q3 2025 · Jun 30, 2024 $14.85M
Net Income Q3 2025 · Mar 31, 2024 −$8.69M
Operating Income Q3 2025 · Sep 30, 2025 −$17.68M
Operating Income Q3 2025 · Sep 30, 2025 −$42.55M
Operating Income Q3 2025 · Sep 30, 2024 −$13.85M
Operating Income Q3 2025 · Sep 30, 2024 −$12.83M
Revenue Q3 2025 · Sep 30, 2025 $16K
Revenue Q3 2025 · Sep 30, 2025 $64K
Revenue Q3 2025 · Sep 30, 2024 $1.22M
Revenue Q3 2025 · Sep 30, 2024 $25.34M